Mesothelin CAR-T cells expressing tumor-targeted immunocytokine IL-12 yield durable efficacy and fewer side effects
Yuankui Zhu(Huazhong Agricultural University), Mingqian Feng(Huazhong Agricultural University), Xiuli Wang(City of Hope), Zilong Zhao(The University of Texas MD Anderson Cancer Center), Xin Chen(Johns Hopkins University), Shuang Dong(Hubei Cancer Hospital), Sheng Hu(Hubei Cancer Hospital), Sina Lan(Huazhong Agricultural University), Junfeng Sheng(Huazhong Agricultural University), Linghe Yue(Huazhong Agricultural University), Dianbao Zuo(Huazhong Agricultural University)
Cited by 24
Related Papers
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
Nanotechnology in Therapeutics: A Focus on Nanoparticles as A Drug Delivery System
|Nanomedicine|2012|609
A transgene-encoded cell surface polypeptide for selection, in vivo tracking, and ablation of engineered cells
|Blood|2011|600
Activatable Fluorescence/MRI Bimodal Platform for Tumor Cell Imaging via MnO<sub>2</sub> Nanosheet–Aptamer Nanoprobe
|Journal of the American Chemical Society|2014|585
A Smart Photosensitizer–Manganese Dioxide Nanosystem for Enhanced Photodynamic Therapy by Reducing Glutathione Levels in Cancer Cells
|Angewandte Chemie International Edition|2016|573